CIK 0001453687 · Non-accelerated filer<br>Smaller reporting company
Cartesian Therapeutics, Inc.
Sign in to watch- Ticker
- RNAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 301-348-8698
- Business address
- 7495 NEW HORIZON WAY, FREDERICK, MD, 21703
- Former names
- SELECTA BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-13 | SPRINGER TIMOTHY A Director | Purchase | +8,983 | $17.78 | $160K | 8,527,440 |
| 2025-01-10 | Jewell Christopher M Chief Scientific Officer | Option exercise | +9,000 | $3.23 | $29K | 62,490 |
| 2025-01-10 | Jewell Christopher M Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −9,000 | 67,432 | ||
| 2025-01-06 | Kurtoglu Metin Chief Technology Officer | Sale | −2,458 | $16.83 | $41K | 62,258 |
| 2025-01-06 | Miljkovic Milos Chief Medical Officer | Sale | −948 | $16.83 | $16K | 35,393 |
| 2025-01-06 | Jewell Christopher M Chief Scientific Officer | Sale | −1,286 | $16.83 | $22K | 53,490 |
| 2025-01-06 | English Emily Chief Operations Officer | Sale | −906 | $16.83 | $15K | 40,226 |
| 2025-01-06 | Brunn Carsten President and CEO | Sale | −8,708 | $16.83 | $147K | 204,096 |
| 2025-01-06 | Davis Blaine Chief Financial Officer | Sale | −4,028 | $16.83 | $68K | 94,811 |
| 2025-01-03 | Kurtoglu Metin Chief Technology Officer | Sale | −2,417 | $16.72 | $40K | 64,716 |
| 2025-01-03 | Miljkovic Milos Chief Medical Officer | Sale | −932 | $16.72 | $16K | 36,341 |
| 2025-01-03 | Jewell Christopher M Chief Scientific Officer | Sale | −1,264 | $16.72 | $21K | 54,776 |
| 2025-01-03 | English Emily Chief Operations Officer | Sale | −891 | $16.72 | $15K | 41,132 |
| 2025-01-03 | Brunn Carsten President and CEO | Sale | −8,563 | $16.72 | $143K | 212,804 |
| 2025-01-03 | Davis Blaine Chief Financial Officer | Sale | −3,961 | $16.72 | $66K | 98,839 |
| 2025-01-02 | Brunn Carsten President and CEO | Grant or award | +57,500 | 221,367 | ||
| 2025-01-02 | Brunn Carsten President and CEO | Grant or award · Employee Stock Option (right to buy) | +169,100 | 169,100 | ||
| 2025-01-02 | Jewell Christopher M Chief Scientific Officer | Grant or award | +16,100 | 56,040 | ||
| 2025-01-02 | Jewell Christopher M Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +47,400 | 47,400 | ||
| 2025-01-02 | English Emily Chief Operations Officer | Grant or award | +16,100 | 42,023 |
Page 4 of 16 · 316 trades